Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) – Industry Trends and Forecast to 2031.
.
The Global Breast Biopsy Devices Market size was valued at USD 2.69 USD Billion in 2023.
The Global Breast Biopsy Devices Market is projected to grow at a CAGR of 7.45% during the forecast period of 2024 to 2031.
The major players operating in the market include Various companies ,luding Scion Medical Technologies LLC, STERYLAB S.r.l., ARGON MEDICAL, Danaher, Cianna Medical, Benetec, Cigna, United Medical Systems , Stryker, BD, Hologic , Devicor Medical Products , etc.-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
